Common Contracts
435 similar Underwriting Agreement contracts by Biohaven Ltd., IVERIC Bio, Inc., Natera, Inc., others
●] Shares VOYAGER TECHNOLOGIES, INC. CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 2nd, 2025 • Voyager Technologies, Inc./De • Guided missiles & space vehicles & parts • New York
25,000,000 Shares AKEBIA THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • March 20th, 2025 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • New York
•] Shares AARDVARK THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2025 • Aardvark Therapeutics, Inc. • Pharmaceutical preparations • New York
40,000,000 Shares JOBY AVIATION, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT October 24, 2024Underwriting Agreement • October 28th, 2024 • Joby Aviation, Inc. • Aircraft • New York
5,263,158 Shares BIOHAVEN LTD. COMMON SHARES, WITHOUT PAR VALUE UNDERWRITING AGREEMENTUnderwriting Agreement • October 2nd, 2024 • Biohaven Ltd. • Pharmaceutical preparations • New York
4,300,000 Shares SONIDA SENIOR LIVING, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • August 19th, 2024 • Sonida Senior Living, Inc. • Services-nursing & personal care facilities • New York
78,740,157 Shares PLUG POWER INC. COMMON STOCK, par value $0.01 per share UNDERWRITING AGREEMENTUnderwriting Agreement • July 22nd, 2024 • Plug Power Inc • Electrical industrial apparatus • New York
The undersigned understands that you, as representative of the several Underwriters (as defined below), propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Plug Power Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Offering”) by the several Underwriters (the “Underwriters”), of shares (the “Shares”) of common stock, par value $0.01 per share, of the Company (the “Common Stock”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.
Shares ALUMIS INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 24th, 2024 • Alumis Inc. • Pharmaceutical preparations • New York
Alumis Inc., a Delaware corporation (the “Company”), proposes, subject to terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom Morgan Stanley & Co. LLC, Leerink Partners LLC, Cantor Fitzgerald & Co. and Guggenheim Securities, LLC are acting as representatives (the “Representatives”), [_________] shares of its common stock, par value $0.0001 per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional [_________] shares of its common stock, par value $0.0001 per share (the “Additional Shares”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The
●] Shares TEMPUS AI, INC. CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT June [●], 2024Underwriting Agreement • June 5th, 2024 • Tempus AI, Inc. • Services-computer programming, data processing, etc. • New York
5,609,757 Shares BIOHAVEN LTD. COMMON SHARES, WITHOUT PAR VALUE UNDERWRITING AGREEMENTUnderwriting Agreement • April 22nd, 2024 • Biohaven Ltd. • Pharmaceutical preparations • New York
The undersigned understands that J.P. Morgan Securities LLC (the “Representative”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Biohaven Ltd., a British Virgin Islands business company limited by shares (the “Company”), providing for the public offering (the “Offering”) by one or more underwriters, including the Representative, named in Schedule I to the Underwriting Agreement (the “Underwriters”) of Common Shares, without par value, of the Company (the “Common Shares”).
2,472,581 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) PRE-FUNDED WARRANTS TO PURCHASE 18,577,419 SHARES OF COMMON STOCK TScan Therapeutics, Inc. UNDERWRITING AGREEMENT April 16, 2024Underwriting Agreement • April 17th, 2024 • TScan Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Shares LOAR HOLDINGS INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • April 17th, 2024 • Loar Holdings, LLC • Aircraft parts & auxiliary equipment, nec • New York
AUNA S.A. Class A Ordinary Shares, with a nominal value of US$0.01 per Share UNDERWRITING AGREEMENTUnderwriting Agreement • January 25th, 2024 • Auna S.A. • Services-offices & clinics of doctors of medicine • New York
•] Shares CG ONCOLOGY, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • January 18th, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • New York
4,550,000 Shares NATERA, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • September 7th, 2023 • Natera, Inc. • Services-medical laboratories • New York
Natera, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives,” “you,” “your”), an aggregate of 4,550,000 shares of its common stock, par value $0.0001 per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 682,500 shares of its common stock, par value $0.0001 per share (the “Additional Shares”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, par value $0.0001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are herein
20,000,000 Shares ALLOVIR, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 26th, 2023 • Allovir, Inc. • Biological products, (no disgnostic substances) • New York
The undersigned understands that J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and BofA Securities, Inc. propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with AlloVir, Inc., a Delaware corporation (the “Company”), as representatives (the “Representatives”) of the several underwriters listed in Schedule I to the Underwriting Agreement (the “Underwriters”), providing for the public offering (the “Public Offering”) by the several Underwriters of shares (the “Shares”) of the common stock, par value $0.0001 per share, of the Company (the “Common Stock”).
12,500,000 Shares EDITAS MEDICINE, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 15th, 2023 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • New York
11,032,656 Shares ZENTALIS PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • June 15th, 2023 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Morgan Stanley & Co. LLC Jefferies LLC SVB Securities LLC c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 c/o Jefferies LLC 520 Madison Avenue New York, New York 10022 c/o SVB Securities LLC 1301 Avenue of the Americas, 12th Floor New York, New York 10019
22,989,474 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) PRE-FUNDED WARRANTS TO PURCHASE 47,010,526 SHARES OF COMMON STOCK TScan Therapeutics, Inc. UNDERWRITING AGREEMENT May 25, 2023Underwriting Agreement • May 31st, 2023 • TScan Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
] Shares ACELYRIN, INC. COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • May 1st, 2023 • ACELYRIN, Inc. • Pharmaceutical preparations • New York
13,350,000 Shares IVERIC BIO, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • December 5th, 2022 • IVERIC Bio, Inc. • Pharmaceutical preparations • New York
11,430,000 Shares NATERA, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 16th, 2022 • Natera, Inc. • Services-medical laboratories • New York
Natera, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives,” “you,” “your”), an aggregate of 11,430,000 shares of its common stock, par value $0.0001 per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 1,714,500 shares of its common stock, par value $0.0001 per share (the “Additional Shares”) if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, par value $0.0001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are here
•] Shares ACRIVON THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 3rd, 2022 • Acrivon Therapeutics, Inc. • Pharmaceutical preparations • New York
10,330,000 Shares ZENTALIS PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • May 16th, 2022 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
c/o Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036 c/o Jefferies LLC 520 Madison Avenue New York, NY 10022 c/o SVB Securities LLC 1301 Avenue of the Americas, 12th Floor New York, NY 10019
] Shares CINCOR PHARMA, INC. COMMON STOCK, $0.00001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • January 3rd, 2022 • CinCor Pharma, Inc. • Pharmaceutical preparations • New York
As Representatives of the several Underwriters listed in Schedule I to the Underwriting Agreement referred to below Ladies and Gentlemen:Underwriting Agreement • January 3rd, 2022 • Vigil Neuroscience, Inc. • Biological products, (no disgnostic substances) • New York
•] Shares SAMSARA INC. CLASS A COMMON STOCK PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • December 6th, 2021 • Samsara Inc. • Services-computer integrated systems design • New York
•] Shares HASHICORP, INC. CLASS A COMMON STOCK (PAR VALUE $0.000015 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • November 29th, 2021 • HashiCorp, Inc. • Services-computer programming services • New York
4,000,000 Shares REPARE THERAPEUTICS INC. COMMON SHARES (NO PAR VALUE) UNDERWRITING AGREEMENTUnderwriting Agreement • November 1st, 2021 • Repare Therapeutics Inc. • Pharmaceutical preparations • New York
•] Shares IO Biotech, Inc. COMMON STOCK (PAR VALUE [•]) UNDERWRITING AGREEMENTUnderwriting Agreement • November 1st, 2021 • IO Biotech, Inc. • Pharmaceutical preparations • New York
•] Shares Rivian Automotive, Inc. Class A Common Stock, Par Value $0.001 Per Share UNDERWRITING AGREEMENTUnderwriting Agreement • November 1st, 2021 • Rivian Automotive, Inc. / DE • Motor vehicles & passenger car bodies • New York
l ] Shares NERDWALLET, INC. CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 26th, 2021 • Nerdwallet, Inc. • Services-computer processing & data preparation • New York
9,000,000 Shares IVERIC BIO, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 25th, 2021 • IVERIC Bio, Inc. • Pharmaceutical preparations • New York
•] Shares UDEMY, INC. COMMON STOCK ($0.00001 PAR VALUE PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • October 20th, 2021 • Udemy, Inc. • Services-educational services • New York
●] Shares FLUENCE ENERGY, INC. CLASS A COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 19th, 2021 • Fluence Energy, Inc. • Miscellaneous electrical machinery, equipment & supplies • New York
The undersigned understands that J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, (the “Representatives”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Fluence Energy, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including the Representatives (the “Underwriters”), of shares of the Class A common stock, par value $0.00001 per share, of the Company (the “Class A Shares”). As used herein, the term “Common Stock” refers to shares of the Company’s common stock, including any shares of Class A Shares.